exenatide and placebo

DRUG2 trials

Sponsors

AstraZeneca

Conditions

Type 2 Diabetes Mellitus

Phase 1

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

CompletedNCT00517283

AstraZenecaType 2 Diabetes Mellitus

Start: 2005-01-31End: 2005-06-30Updated: 2015-02-23

A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

CompletedNCT00517283

AstraZenecaType 2 Diabetes Mellitus

Start: 2005-01-31End: 2005-06-30Updated: 2015-02-23

Phase 4

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

CompletedNCT00870194

AstraZenecaType 2 Diabetes Mellitus

Start: 2009-03-31End: 2010-04-30Updated: 2015-04-09